RISING PHARMACEUTICALS 2022-03-02 Health serious FDA
Health · FDA · Recall #FDA-D-0573-2022
Methylphenidate Hydrochloride Chewable Tablets, 2.5 mg, 100-count bottle, Rx Only,… Recall
Issued March 2, 2022 · RISING PHARMACEUTICALS
In March 2022, RISING PHARMACEUTICALS recalled the Methylphenidate Hydrochloride Chewable Tablets, 2.5 mg, 100-count bottle, Rx Only,…, a serious health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Failed Tablet Specifications: Recall of this drug product was voluntarily initiated by the manufacturer due to a market complaint, which stated that a tablet in the sealed bottle was twice larger in size when compared to the remaining tablets. This complaint is second of its kind.
What you should do
- 1 Stop using Methylphenidate Hydrochloride Chewable Tablets, 2.5 mg, 100-count bottle, Rx Only,… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact RISING PHARMACEUTICALS to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- RISING PHARMACEUTICALS
- Category
- Health
- Recall date
- March 2, 2022
- Units affected
- Not reported
- Sold at
- Nationwide in the USA
- Recall number
- FDA-D-0573-2022
- Made in
- United States
- Issuing agency
- FDA
In context
- RISING PHARMACEUTICALS has 2 recalls in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 870th Health recall we've logged in 2022.